News


Jan 07 2015

OticPharma Announces Positive Results from a Phase II Trial of FoamOtic Externa

REHOVOT, Israel–(BUSINESS WIRE)–OticPharma, a privately held biopharmaceutical company focused on the development of innovative retained, localized foam based products for Ear, Nose and Throat (ENT) disorders, announces positive clinical results of its lead product, FoamOtic Externa. A single agent, steroid free product was studied in a Phase 2 clinical trial with 220 minor and adult […]

Jul 02 2013

OticPharma recently volunteered to treat Pedang, a rare Sumatran tiger suffering from recurrent ear infections, with an experimental foam based medication

(Video) OticPharma Treats Ailing Tiger’s Chronic Ear Infection with Novel Experimental Therapeutic Foam Israeli pharmaceutical company Otic Pharma recently volunteered to treat Pedang, a rare Sumatran tiger suffering from recurrent ear infections, with an experimental foam based medication. Contacts

Feb 26 2012

Ear treatment co Otic Pharma raises $4.3m from Orbimed

Otic Pharma is developing foam-based drugs for ear infections for children and dogs. OrbiMed Advisors LLC has invested $4.3 million in Otic Pharma Ltd., which is developing treatments for diseases of the ear. The company’s treatments are based on foam, called “Foam-Otic”, rather than drops. Foam-delivery is better than drops, because foams stay in place […]